Skip to main content
OpenTrials

Clinical trial condition

Skin Neoplasms

Explore clinical trials studying Skin Neoplasms. Study availability and eligibility vary by location and protocol.

2,110 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Skin Neoplasms trial results

Completed

A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

NCT03289962

Conditions
Bladder Cancer, Breast Diseases, Breast Neoplasms, +48 more
Locations
  • HonorHealth Research Institute ? Bisgrove Scottsdale, Arizona, United States
  • The Los Angeles Clinic Los Angeles, California, United States
  • UCSF Comprehensive Cancer Ctr San Francisco, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 33 locations
View Trial Details
Completed

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

NCT02220985

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +57 more
Locations
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma

NCT02073123

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +12 more
Locations
  • Augusta University Augusta, Georgia, United States
  • University of Iowa Hospital and Clinics Iowa City, Iowa, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • New Mexico Cancer Center Alliance Albuquerque, New Mexico, United States
View Trial Details
Completed

Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)

NCT04305054

Conditions
Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms, +11 more
Locations
  • The Angeles Clinic and Research Institute ( Site 2009) Los Angeles, California, United States
  • UCLA Hematology & Oncology ( Site 2004) Los Angeles, California, United States
  • Providence Saint John's Health Center ( Site 2010) Santa Monica, California, United States
  • University of Colorado, Anschutz Cancer Pavilion ( Site 2012) Aurora, Colorado, United States
View all 60 locations
View Trial Details

Related conditions